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Purpose: To investigate the incidence of bladder cancer (BC) in Sri Lanka and to com-
pare risk factors and outcomes with those of other South Asian nations and South Asian 
migrants to the United Kingdom (UK) and the United States (US). 
Materials and Methods: The incidence of BC in Sri Lanka was examined by using two 
separate cancer registry databases over a 5-year period. Smoking rates were compiled 
by using a population-based survey from 2001 to 2009 and the relative risk was calcu-
lated by using published data.
Results: A total of 637 new cases of BC were diagnosed over the 5-year period. Sri Lankan 
BC incidence increased from 1985 but remained low (1.36 and 0.3 per 100,000 in males 
and females) and was similar to the incidence in other South Asian countries. The in-
cidence was lower, however, than in migrant populations in the US and the UK. In 
densely populated districts of Sri Lanka, these rates almost doubled. Urothelial carci-
noma accounted for 72%. The prevalence of male smokers in Sri Lanka was 39%, where-
as Pakistan had higher smoking rates with a 6-fold increase in BC.
Conclusions: Sri Lankan BC incidence was low, similar to other South Asian countries 
(apart from Pakistan), but the actual incidence is likely higher than the cancer registry 
rates. Smoking is likely to be the main risk factor for BC. Possible under-reporting in 
rural areas could account for the low rates of BC in Sri Lanka. Any genetic or environ-
mental protective effects of BC in South Asians seem to be lost on migration to the UK 
or the US and with higher levels of smoking, as seen in Pakistan. 
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INTRODUCTION
Bladder cancer (BC) is the sixth most common cancer in the 
world, with an estimated 294,345 men and 88,315 women 
diagnosed with the disease and with 5-year survival rates 
varying from 40 to 80% [1,2]. In South Asia, the reported 
rate of BC is estimated to be about 2.1 per 100,000 [1], but 
there is currently no accurate estimate of the incidence of 
BC in Sri Lanka.
Age and male gender are known risk factors for BC, 
whereas other environmental risk factors include smoking 
and exposure to organic compounds such as the aromatic 
amines beta-naphthalene, benzidine, and 4-aminobiphe-
nyl [3]. 
Transitional cell carcinomas (TCCs) are the most com-
mon type of BC, accounting for 95 to 97% in Europe [4]. In 
some African and Middle Eastern countries, squamous cell 
carcinoma is much more common as the result of chronic Korean J Urol 2012;53:304-309
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schistosomiasis infection [4]. 
We aimed to investigate the rate of BC in Sri Lanka by 
using the cancer registry data and to compare this with in-
cidences in the neighboring countries of India and Pakistan 
as well as in South Asian migratory populations in the 
United Kingdom (UK) and the United States (US). The ef-
fects of smoking were analyzed to identify any effect on BC 
rates in Sri Lanka.
MATERIALS AND METHODS
Sri Lanka, an island nation adjacent to the Indian subcon-
tinent, has a population of 19 million people with Colombo, 
Gampaha, Kalutara, and Kandy districts having the high-
est population densities. Sri Lanka has a free public health 
care system similar to that of the National Health Service 
in the UK. In 2004 the Sri Lankan public health sector had 
10,479 physicians with 6 physicians and 29 hospital beds 
per 10,000 persons, [5] which is similar to the public health 
systems of India (8 physicians per 10,000) and Pakistan (6 
physicians per 10,000) [5]. The Sri Lankan public health 
care system serves the majority of the population, whereas 
the private health care system caters to a minority in the 
more developed cities.
1. Cancer incidence databases
The National Cancer Control Programme (NCCP) is the 
central collection agency for cancer data in Sri Lanka. New 
diagnoses of BC are recorded by the NCCP, who analyze, 
verify the diagnosis, and follow up records for 2 to 3 years 
from the diagnosis. The NCCP continuously monitors the 
data for any discrepancies and re-verifies any incon-
sistencies by tracing the initial source to ensure reliability. 
These data are used to build up the national cancer 
registry. The BC data (ICD-10 C67) supplied to us were 
verified by the NCCP and were collected immediately prior 
to the publication. More than 80% of the data are based on 
histological diagnoses (personal communication). To en-
sure reliability, we also analyzed BCs from the histopatho-
logical laboratories of the National Hospital of Sri Lanka 
(NHSL) for 2009 and 2010. The histopathological labo-
ratories receive all specimens from the NHSL Urology 
wards, which admits patients mainly from the western 
province of Sri Lanka (comprising of Colombo, Gampaha, 
and Kalutara districts), and are analyzed and reported by 
consultant pathologists.
Smoking rates in Sri Lanka were provided to us by the 
Alcohol and Drug Information Center (ADIC) Sri Lanka. 
ADIC Sri Lanka conducts a bi-annual “spot” survey in 
1,500 males aged 15 years and over by means of a ques-
tionnaire over a 2-week period and is carried out in the 4 
most populated districts of Sri Lanka as well as in 
Anuradhapura (a rural district) and a randomly selected 
district. These smoking rates were analyzed and compared 
with those of other South Asian countries as well as the mi-
grant population of the UK and the US.
2. Statistical methods
The age-specific and age-standardized incidences of BC in 
Sri Lanka were calculated by using 5-year age bands for the 
period 2001 to 2005 with use of the 2001 national consensus 
data (estimated growth rate according to World Bank de-
velopment indicators [6]) and were standardized by using 
the hypothetical Segi’s world population, which was de-
vised by cancer epidemiologist Segi [7]. Separate gen-
der-specific rates and rates for the main cities were calcu-
lated by using the methods described above.
RESULTS
1. Incidence of BC in Sri Lanka
There were 514 new cases of BC in males and 123 in females 
over the 5-year period of analysis of an estimated 9,247,283 
males and 9,433,225 females (between 83 and 118 per year 
in males and between 15 and 34 per year in females) with 
mean ages of 64 and 62 years at diagnosis, respectively. The 
overall incidence of BC in Sri Lanka remained low at 0.8 
per 100,000; however, the age-adjusted rate of BC has in-
creased since 1985. 
There was no accurate population consensus in the north 
and eastern parts of the country (Jaffna, Mannar, Vavu-
niya, Mullaitivu, Killinochchi, Batticaloa, and Trincoma-
lee districts) owing to the civil war in those areas at the 
time. Furthermore, these areas accounted for only 10 male 
cases and 7 female cases in the 5 years. Therefore, these 
areas were excluded and the data from the other 18 districts 
were analyzed (Fig. 1). 
The highest rates of BC were seen in the 4 most populated 
districts, of which Colombo, the most populated district, 
had the highest rates (2.17 per 100,000 in males and 0.62 
per 100,000 in females) (Fig. 2). 
The incidence of BC in Sri Lanka increased with age and 
with peak rates in males between 70 and 74 years of age 
(14.24 per 100,000) and in females aged 75 years and older 
(2.32 per 100,000) (Fig. 3). 
Of the BCs in Sri Lanka, 72% were TCCs, with a 
male-to-female ratio of 4:1. The rest of the tumors were 
categorized as squamous cell carcinoma (9%), adenocar-
cinoma (3%), “other” (7%), and “unspecified malignant neo-
plasms of the bladder” (9%). Squamous cell carcinomas 
(11%) and adenocarcinomas (4%) were found more fre-
quently in females than in males (9% and 3%, respectively). 
Although a significant proportion of the TCC staging da-
ta was missing (62%), of the available data, 94% (158 out 
of 167) were pT2 or greater at presentation, which sug-
gested that most tumors presented at an advanced stage. 
In keeping with the NCCP cancer registry database, the 
NHSL data for Colombo had 70 new diagnoses of BC over 
the 2-year period with a mean age of 65.4 years. Of these 
patients, 84.3% were male and TCCs accounted for 92.9% 
of BC with 45.7% of these being high grade and but only 
27.1% being pT2.Korean J Urol 2012;53:304-309
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FIG. 1. Map of Sri Lanka denoting the districts and population 
estimates for 2005. Shaded districts were excluded from the 
study to ensure data reliability. 
FIG. 2. Rates of bladder cancer in Sri Lanka by district and 
published rates of India [9] and Pakistan [10].
FIG. 3. Age-specific incidence of bladder cancer in males (A) and females (B). Rates adjusted to 10  year age bands to compare with the 
Indian [9] and Pakistani incidence data [10].
2. Risk factors
On average, 38.6% of Sri Lankan males are reported as be-
ing smokers with the highest rates seen in the 25- to 
39-year-old age group. Interestingly, the smoking rates in 
the highly populated districts were lower than in the rural 
districts (34.2% in Colombo vs. 43.1 % in Anuradhapura).
DISCUSSION
BC was the 15th most common cancer in Sri Lanka in 2000 
[8]. During the 5-year period of analysis, the cancer registry 
data showed an overall increase in the rate of BC in Sri 
Lanka but this was lower than the Globocan estimates 
(1.36 and 0.3 per 100,000 vs. 2.2 and 0.5 per 100,000) [1]. 
However, in the analysis of individual district-level data, 
Colombo, which had the highest population and better 
health care access and data collection, showed an incidence 
of BC in both males and females that was higher than the 
Globocan estimated incidence (Fig. 2) [1]. Although is it 
possible that increasing BC rates in Sri Lanka could ac-
tually be due to improvements in data collection rather 
than to a true increase in incidence, it is evident that BCs Korean J Urol 2012;53:304-309
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TABLE 1. Overall male and female incidence of bladder cancer in Sri Lanka and comparison with India, Pakistan and Bangladesh and 
comparison with the rates in the migrant population in the United Kingdom and United States
Country
Males Females
Rate Relative risk Rate Relative risk
Sri Lanka  (2001-2005)
India  (1993-1997) [9] 
Karachchi, Pakistan (1995-1997) [10] 
UK [1]
South Asian migrants to UK (1990-1992) [23] 
South Asian migrants to UK (1999-2001) [9] 
US [24]
South Asian migrants to US (1999-2001) [9] 
South Asian migrants to California (1993-1997) [25] 
1.36/(2.17)
a
  3.2
  8.9
11.7
  8.4
  7.0
37.2
6.8-7.9
  3.2
1.00
2.35/(1.47)
a
6.54/(4.10)
a
8.06/(5.39)
a
6.18/(3.87)
a
5.15/(3.23)
a
27.35/(17.14)
a
5.37/(3.39)
a
2.35/(1.47)
a
0.3/(0.62)
a
0.7
3.4
3.3
1.9
1.9
9.2
2.4-2.8
-
1.00
 2.33/(1.13)
a
11.33/(5.48)
a
   11/(5.32)
a
6.33/(3.06)
a
6.33/(3.06)
a
30.67/(14.84)
a
8.67/(4.19)
a
-
a: The figures in italics within brackets denote rates relative to the rates of Colombo (2001-2005).
in the rural districts present late as seen by the higher pro-
portion of BCs that were pT2 or greater compared with the 
cases of Colombo. Therefore, it is also likely that the in-
cidence of BC, especially in the rural districts, could be un-
derreported and that the rates in Colombo reflect the true 
incidence of BC in Sri Lanka.
Although the incidence of BC in Sri Lanka was lower 
than the incidences in India and Pakistan, the rates in 
Colombo were comparable with those of India and 
Bangladesh (Fig. 2) [1,9,10]. Surprisingly, Pakistan had 
the highest incidence of BC among the South Asian coun-
tries (Fig. 1) [10]. 
The majority (72%) of the BCs in Sri Lanka were TCCs, 
which was lower than the NHSL data, the rates in other 
South Asian countries, and previously reported rates 
(93.4%) [11]. The significant number of tumors categorized 
as “unspecified carcinomas” in the cancer registry data, 
better hospital access, and data collection influencing the 
NHSL data could explain these differences. Squamous cell 
BCs are commonly associated with schistosomiasis in-
fection, as seen in Egypt [2]. Although these accounted for 
9% of the cancer registry BCs, the reported schistosomias 
infections have been limited to a few case reports in India, 
Pakistan, and Sri Lanka [12]. There was a higher incidence 
of adenocarcinoma of the bladder in females in Sri Lanka 
(4%), India (5%), and Pakistan (7%) than in the males of 
each of the countries (3%, 3%, and 2%, respectively). These 
higher rates of adenocarcinoma of the bladder in females 
could be due to the subtype of adenocarcinoma, clear cell 
adenocarcinoma, which arises from the female genital 
tract [13].
Smoking is a well-documented risk factor for BC and ac-
counts for 50% of BC in males and 23% of BC in females [14]. 
It is interesting that, although many South Asian countries 
report a low prevalence of tobacco smoking, other forms of 
smokeless tobacco use such as inhalation (beedi) and chew-
ing are commonly practiced and are largely underreported 
[15]. Therefore, the high incidence of BC in Pakistan is most 
likely attributed to increased tobacco use, as confirmed by 
the corresponding incidence of lung cancer [10] and also the 
high level of oral cancer, which is an indirect indicator of 
alternate forms of tobacco consumption [10]. Pakistan had 
the highest rate of female smokers (2.8%) which was re-
flected by the corresponding incidence of BC in females 
(Table 1). This incidence is likely to be compounded by in-
creased passive-smoking rates and by the percentages of 
female users of smokeless tobacco (up to 47% of non-ciga-
rette smokers) [15]. Similarly, in Sri Lanka, the cancer reg-
istry data showed that the leading sites of cancer in men 
in 2005 were the lip, oral cavity and pharynx, lung, and 
esophagus, in keeping with the relatively high prevalence 
of tobacco smoking and smokeless tobacco use in Sri 
Lankan males (24.5 [16] to 38.56% [ADIC]). Although spec-
ulative, the higher prevalence of male smokers found in the 
rural districts with a high proportion of late presentations 
of BCs in these areas may imply that the actual rates of BC 
in these districts could be even higher than in Colombo. 
Beta-naphthylamine used by workers in the dye and rub-
ber industries has been identified as a carcinogen for BC 
[17]. A large proportion of the South Asian economy is de-
pendent on the manufacture and export of textiles and rub-
ber products (Fig. 4); however, there was no corresponding 
increase in the incidence of BC. 
The widespread use of pesticides is also thought to be 
linked to BC, but the use of these is likely similar between 
these countries.
1. Migrant South Asian population
The migrant South Asian population to the UK and the US 
had a higher incidence of BC than that in Sri Lanka, India, 
and Bangladesh (Table 1), with a 5- to 6-fold increase in the 
UK and a 2- to 5-fold increase in the US compared with Sri 
Lanka. However, the BC incidence rates in Pakistan were 
similar to or higher than the BC incidence rates in the mi-
grant Asians in the UK and the US (Table 1).
Similarly, other cancers such as lung, breast, and pros-
tate cancers have been shown to be higher in South Asian 
migrants to the UK and the US than in the South Asian pop-
ulation living in South Asia [9,18]. Although this could be 
due to better data collection, detection methods, and higher Korean J Urol 2012;53:304-309
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FIG. 4. Percentage of government workforce in each country 
employed in the occupations ‘at risk’. (compiled using the 
government statistics of Labour in each country) [20-22].
awareness in the UK and the US, this could also be a true 
environmental effect as shown by the Multiethnic cohort 
(MEC) study, in which Japanese immigrants to Hawaii ini-
tially had different incidences of cancers (such as breast 
and stomach) than those of the native Hawaiian pop-
ulation, but by the second generation, the incidences had 
become similar [19]. Therefore, as seen by our findings, 
there may also be a genetic, environmental, or dietary pro-
tection in the population living in South Asia.
A limitation of the present study is the data collection by 
the NCCP, especially in the war areas; thus, the incidence 
of BC is likely to be underrepresented. We tried to correct 
for this by excluding the war areas in our analysis, while 
emphasizing districts with better data collection facilities 
and by analyzing the NHSL data to confirm the incidence 
of BC in Sri Lanka. Additionally, the detection methods 
and the initial tests aiding diagnosis may differ between 
the countries compared. Also, the limitations of the “spot 
methodology” conducted by the ADIC are minimized by a 
bi-annual survey that is conducted in a repeatable manner 
in different areas.
CONCLUSIONS
The incidence of BC in Sri Lanka was low, in keeping with 
the BC rates in South Asian countries such as India. 
However, the rates of BC in Pakistan were much higher 
than in other South Asian countries, in keeping with the 
high rates of smoking. With comparatively high smoking 
rates in the rural areas of Sri Lanka along with under-
reporting of BC, the incidence of BC in Sri Lanka is likely 
to be higher than the cancer registry data and may be sim-
ilar to the reported rates of Colombo. 
Remarkably, the migrant South Asian populations to the 
UK and the US have an increased incidence of BC compared 
with populations living in South Asian countries (except 
Pakistan), which suggests a genetic or environmental 
protection. Therefore, further studies analyzing the genet-
ic and environmental protection in the South Asian pop-
ulation are warranted.
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